ClinicalTrials.Veeva

Menu

Future Mental Projections in Schizophrenia (FutureProSchiz)

U

University Hospital, Strasbourg, France

Status

Terminated

Conditions

Schizophrenia

Treatments

Other: questionnary

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of the study is to investigate temporal organization of future thinking in patients with schizophrenia. Patients and control participants will be asked to envision and briefly describe ten personal future events using a cue-words list. Then they will be asked to describe everything that came to their minds (i.e. to think aloud) while they attempted to determine when an event will likely occur. The investigators will compare the proportion of several predefined strategies mentioned by the two groups of participants to locate future events in time. The investigators predict that patients will envision less personal future events and will rely to a lesser extent on strategies to locate events in time, than control participants.

Enrollment

56 patients

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • for patients only
  • male or female
  • age limits : 18-55 years old
  • under the protection of health insurance
  • who have signed up the consent form
  • schizophrenia or schizo-affective disorder according to the DSM-5 criteria (APA, 2013).
  • clinically stable for at least 2 months
  • patients under guardianship or curatorship need agreement of their legal representative
  • informed of the results of prior medical examination for controls only
  • male or female
  • age limits : 18-55 years old
  • under the protection of health insurance
  • who have sign up the consent form
  • recruited from the general population and matched on gender, age years of schooling
  • no psychiatric history (DSM-5)

Exclusion criteria

  • for both patients and controls
  • current severe or unstable somatic illness
  • neurological history (brain injury > 15 minutes loss of consciousness , epilepsia, brain surgery...)
  • current substance use disorder (DSM-5)
  • current major depressive disorder (CDSS,BDI, HDRS)
  • mental retardation (IQ < 70, WAIS-4, f-NART)
  • history of general anesthesia 3 months prior to the experiment
  • pregnancy declared by the subject
  • breast feeding
  • current legal control
  • in emergency situation
  • included during exclusion period in another experiment
  • for controls only
  • taking of antipsychotic drugs for the 3 weeks prior to inclusion
  • under guardianship or curatorship

Trial design

56 participants in 2 patient groups

Patients with schizophrenia
Description:
Patients with schizophrenia or schizoaffective disorder according to DSM-V criteria
Treatment:
Other: questionnary
Control participants
Description:
- Control participants without psychiatric nor neurological history
Treatment:
Other: questionnary

Trial contacts and locations

1

Loading...

Central trial contact

Fabrice BERNA, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems